Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion type Assertion NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_head.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion evidence source_evidence_literature NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion SIO_000772 11244573 NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion wasDerivedFrom befree-2016 NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.
- NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_assertion wasGeneratedBy ECO_0000203 NP310746.RASV8yMA3emYbdL1vjr9b3MW7kbUPIbRZRsb1qlD8hsTY130_provenance.